Avanos Medical Inc expected to post earnings of 29 cents a share - Earnings Preview

Avanos Medical

29/07/2024 17:21

* Avanos Medical Inc  AVNS.N   AVNS.K  is expected to show a
rise
in quarterly revenue when it reports  results on July 31 for the
period ending June 30 2024
    * The Alpharetta Georgia-based  company is expected to
report a
0.7% increase in revenue to $170.667 million from $169.4 million
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Avanos Medical Inc is
for
earnings of 29 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Avanos
Medical
Inc is $23.50​, above​ its last closing price of $23.14. ​​​

The company's guidance on May 2 2024 for the period ended June
30 was for gross profit margin of 60%.
Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   0.21        0.21       0.19      Missed  -11.5
 Sep. 30 0001  0.37        0.37       0.32      Missed  -12.7
 Sep. 30 2023  0.28        0.28       0.37      Beat    50​
 Jan. 1 0001   0.28        0.30       0.37      Beat    24.2
 ​​Jan.        0.27        0.27       0.27      Met     -1.5
 1 0001                                                 
 Jan. 1 0001   0.49        0.49       0.60      Beat    22.4​
 Jan. 1 0001   0.35        0.35       0.38      Beat    7.8
 Jun. 30 2022  0.38        0.38       0.41      Beat    7.3
 This summary was machine generated July 29 at 16:21 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)